OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 10
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 10
Showing 10 citing articles:
SARS-CoV-2 spike protein activates NOX2-p66SHC axis via inhibiting SLAMF8 to promote thrombogenesis
Quan Liu, Xizi Luo, Nan Liu, et al.
Research Square (Research Square) (2025)
Closed Access
Quan Liu, Xizi Luo, Nan Liu, et al.
Research Square (Research Square) (2025)
Closed Access
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient
Francisco Tejerina, Daniel Peñas-Utrilla, Marta Herránz, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 147-147
Open Access
Francisco Tejerina, Daniel Peñas-Utrilla, Marta Herránz, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 147-147
Open Access
Evaluation of Genomic Surveillance of SARS-CoV-2 Virus Isolates and Comparison of Mutational Spectrum of Variants in Bangladesh
Abeda Sultana, Laila Anjuman Banu, Mahmud Hossain, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 182-182
Open Access
Abeda Sultana, Laila Anjuman Banu, Mahmud Hossain, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 182-182
Open Access
‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’ – Author’s reply
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 9, pp. 1211-1212
Closed Access | Times Cited: 3
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 9, pp. 1211-1212
Closed Access | Times Cited: 3
Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.
Alberto Enrico Maraolo, Nicola Schiano Moriello, Ivan Gentile
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 9, pp. 1209-1210
Closed Access | Times Cited: 2
Alberto Enrico Maraolo, Nicola Schiano Moriello, Ivan Gentile
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 9, pp. 1209-1210
Closed Access | Times Cited: 2
Hyperimmune Globulins in COVID-19
Yasmin Maor, Oren Zimhony
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Yasmin Maor, Oren Zimhony
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Re: ‘The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID-19’ by Sun et al.
Hui Li, Wang Xia, Guangting Zeng
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1616-1617
Closed Access | Times Cited: 1
Hui Li, Wang Xia, Guangting Zeng
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1616-1617
Closed Access | Times Cited: 1
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
Hovav Azuly, Tali Shafat, Daniel Grupel, et al.
Infectious Diseases and Therapy (2024)
Open Access
Hovav Azuly, Tali Shafat, Daniel Grupel, et al.
Infectious Diseases and Therapy (2024)
Open Access
Pre-exposure prophylaxis of COVID-19 with tixagevimab/cilgavimab (Evusheld) in 63 rituximab-treated patients with ANCA-associated systemic vasculitis: two-year follow-up results
Т. V. Beketova, N. О. Levina, Yu. A. Uskova, et al.
Rheumatology Science and Practice (2024) Vol. 62, Iss. 5, pp. 465-473
Open Access
Т. V. Beketova, N. О. Levina, Yu. A. Uskova, et al.
Rheumatology Science and Practice (2024) Vol. 62, Iss. 5, pp. 465-473
Open Access
